Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

OGI vs SNDL vs CRON vs CGC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OGI
Organigram Global Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$186M
5Y Perf.-80.2%
SNDL
SNDL Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$376M
5Y Perf.-83.0%
CRON
Cronos Group Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$981M
5Y Perf.-60.6%
CGC
Canopy Growth Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$122M
5Y Perf.-99.3%

OGI vs SNDL vs CRON vs CGC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OGI logoOGI
SNDL logoSNDL
CRON logoCRON
CGC logoCGC
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$186M$376M$981M$122M
Revenue (TTM)$280M$937M$193M$294M
Net Income (TTM)$18M$-11M$-9M$-327M
Gross Margin28.9%27.2%32.5%22.8%
Operating Margin-10.2%-0.8%-1.5%-24.1%
Forward P/E9.8x34.3x
Total Debt$9M$170M$2M$348M
Cash & Equiv.$28M$273M$792M$114M

OGI vs SNDL vs CRON vs CGCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OGI
SNDL
CRON
CGC
StockMay 20May 26Return
Organigram Global I… (OGI)10019.8-80.2%
SNDL Inc. (SNDL)10017.0-83.0%
Cronos Group Inc. (CRON)10039.4-60.6%
Canopy Growth Corpo… (CGC)1000.7-99.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: OGI vs SNDL vs CRON vs CGC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: OGI and CRON are tied at the top with 3 categories each — the right choice depends on your priorities. Cronos Group Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
OGI
Organigram Global Inc.
The Value Play

OGI carries the broadest edge in this set and is the clearest fit for value and quality.

  • Better valuation composite
  • 6.5% margin vs CGC's -111.0%
  • 3.4% ROA vs CGC's -29.5%, ROIC -17.8% vs -10.2%
Best for: value and quality
SNDL
SNDL Inc.
The Specific-Use Pick

SNDL plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
CRON
Cronos Group Inc.
The Income Pick

CRON is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • beta 0.98
  • Rev growth 64.4%, EPS growth -100.0%, 3Y rev CAGR 30.6%
  • 14.6% 10Y total return vs CGC's -94.3%
  • Lower volatility, beta 0.98, Low D/E 0.1%, current ratio 19.59x
Best for: income & stability and growth exposure
CGC
Canopy Growth Corporation
The Secondary Option

CGC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCRON logoCRON64.4% revenue growth vs CGC's -9.5%
ValueOGI logoOGIBetter valuation composite
Quality / MarginsOGI logoOGI6.5% margin vs CGC's -111.0%
Stability / SafetyCRON logoCRONBeta 0.98 vs CGC's 1.90, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)CRON logoCRON+38.9% vs CGC's -12.4%
Efficiency (ROA)OGI logoOGI3.4% ROA vs CGC's -29.5%, ROIC -17.8% vs -10.2%

OGI vs SNDL vs CRON vs CGC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OGIOrganigram Global Inc.
FY 2025
International Business To Business
68.9%$26M
Wholesale To Licensed Producers Revenue
24.5%$9M
Direct To Patient Medical Revenue
6.3%$2M
Other Revenue
0.4%$142,000
SNDLSNDL Inc.
FY 2022
Cannabis
100.0%$62M
CRONCronos Group Inc.
FY 2025
Cannabis Flower
74.0%$108M
Cannabis Extracts
25.7%$38M
Product and Service, Other
0.3%$411,000
CGCCanopy Growth Corporation
FY 2024
Canadian Cannabis Net Revenue
57.9%$156M
Storz And Bickel
27.3%$73M
International And Other Revenue
14.8%$40M
Other Revenue
0.0%$0

OGI vs SNDL vs CRON vs CGC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCRONLAGGINGCGC

Income & Cash Flow (Last 12 Months)

Evenly matched — OGI and SNDL and CRON each lead in 2 of 6 comparable metrics.

SNDL is the larger business by revenue, generating $937M annually — 4.8x CRON's $193M. OGI is the more profitable business, keeping 6.5% of every revenue dollar as net income compared to CGC's -111.0%. On growth, CRON holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
RevenueTrailing 12 months$280M$937M$193M$294M
EBITDAEarnings before interest/tax-$9M$49M-$810,000-$32M
Net IncomeAfter-tax profit$18M-$11M-$9M-$327M
Free Cash FlowCash after capex-$36M$53M-$163,766-$86M
Gross MarginGross profit ÷ Revenue+28.9%+27.2%+32.5%+22.8%
Operating MarginEBIT ÷ Revenue-10.2%-0.8%-1.5%-24.1%
Net MarginNet income ÷ Revenue+6.5%-1.2%-4.9%-111.0%
FCF MarginFCF ÷ Revenue-13.0%+5.6%-0.1%-29.3%
Rev. Growth (YoY)Latest quarter vs prior year+48.6%-4.4%+2.0%+20.9%
EPS Growth (YoY)Latest quarter vs prior year+175.0%+32.8%-100.0%+83.8%
Evenly matched — OGI and SNDL and CRON each lead in 2 of 6 comparable metrics.

Valuation Metrics

SNDL leads this category, winning 2 of 4 comparable metrics.
MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
Market CapShares × price$186M$376M$981M$122M
Enterprise ValueMkt cap + debt − cash$172M$301M$190M$293M
Trailing P/EPrice ÷ TTM EPS-13.45x-32.97x-0.28x
Forward P/EPrice ÷ next-FY EPS est.9.82x34.27x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.91x
Price / SalesMarket cap ÷ Revenue1.37x0.54x5.07x0.62x
Price / BookPrice ÷ Book value/share0.69x0.46x0.90x0.34x
Price / FCFMarket cap ÷ FCF8.83x
SNDL leads this category, winning 2 of 4 comparable metrics.

Profitability & Efficiency

CRON leads this category, winning 5 of 9 comparable metrics.

OGI delivers a 4.9% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-43 for CGC. CRON carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CGC's 0.72x. On the Piotroski fundamental quality scale (0–9), SNDL scores 6/9 vs OGI's 2/9, reflecting solid financial health.

MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
ROE (TTM)Return on equity+4.9%-1.0%-0.9%-43.1%
ROA (TTM)Return on assets+3.4%-0.8%-0.8%-29.5%
ROICReturn on invested capital-17.8%-0.3%-0.8%-10.2%
ROCEReturn on capital employed-16.0%-0.4%-0.3%-12.4%
Piotroski ScoreFundamental quality 0–92665
Debt / EquityFinancial leverage0.03x0.15x0.00x0.72x
Net DebtTotal debt minus cash-$19M-$102M-$790M$235M
Cash & Equiv.Liquid assets$28M$273M$792M$114M
Total DebtShort + long-term debt$9M$170M$2M$348M
Interest CoverageEBIT ÷ Interest expense-1.16x-7.79x
CRON leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CRON leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CRON five years ago would be worth $3,342 today (with dividends reinvested), compared to $45 for CGC. Over the past 12 months, CRON leads with a +38.9% total return vs CGC's -12.4%. The 3-year compound annual growth rate (CAGR) favors CRON at 8.9% vs CGC's -55.9% — a key indicator of consistent wealth creation.

MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
YTD ReturnYear-to-date-20.2%-16.7%-4.8%-5.0%
1-Year ReturnPast 12 months+23.2%+11.5%+38.9%-12.4%
3-Year ReturnCumulative with dividends-34.3%-16.2%+29.1%-91.4%
5-Year ReturnCumulative with dividends-87.5%-81.1%-66.6%-99.6%
10-Year ReturnCumulative with dividends-95.6%-98.3%+1457.6%-94.3%
CAGR (3Y)Annualised 3-year return-13.1%-5.7%+8.9%-55.9%
CRON leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CRON leads this category, winning 2 of 2 comparable metrics.

CRON is the less volatile stock with a 0.98 beta — it tends to amplify market swings less than CGC's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRON currently trades 74.9% from its 52-week high vs CGC's 47.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
Beta (5Y)Sensitivity to S&P 5001.33x1.18x0.98x1.90x
52-Week HighHighest price in past year$2.24$2.89$3.43$2.38
52-Week LowLowest price in past year$1.10$1.15$1.84$0.84
% of 52W HighCurrent price vs 52-week peak+61.6%+50.2%+74.9%+47.5%
RSI (14)Momentum oscillator 0–10046.849.749.352.9
Avg Volume (50D)Average daily shares traded632K1.9M1.4M10.4M
CRON leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: OGI as "Buy", SNDL as "Hold", CRON as "Hold", CGC as "Hold". Consensus price targets imply 1180.5% upside for CGC (target: $14) vs -10.5% for CRON (target: $2).

MetricOGI logoOGIOrganigram Global…SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.CGC logoCGCCanopy Growth Cor…
Analyst RatingConsensus buy/hold/sellBuyHoldHoldHold
Price TargetConsensus 12-month target$3.95$2.30$14.47
# AnalystsCovering analysts561526
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.0%+1.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CRON leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). SNDL leads in 1 (Valuation Metrics). 1 tied.

Best OverallCronos Group Inc. (CRON)Leads 3 of 6 categories
Loading custom metrics...

OGI vs SNDL vs CRON vs CGC: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is OGI or SNDL or CRON or CGC a better buy right now?

For growth investors, Cronos Group Inc.

(CRON) is the stronger pick with 64. 4% revenue growth year-over-year, versus -9. 5% for Canopy Growth Corporation (CGC). Analysts rate Organigram Global Inc. (OGI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — OGI or SNDL or CRON or CGC?

Over the past 5 years, Cronos Group Inc.

(CRON) delivered a total return of -66. 6%, compared to -99. 6% for Canopy Growth Corporation (CGC). Over 10 years, the gap is even starker: CRON returned +1458% versus SNDL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — OGI or SNDL or CRON or CGC?

By beta (market sensitivity over 5 years), Cronos Group Inc.

(CRON) is the lower-risk stock at 0. 98β versus Canopy Growth Corporation's 1. 90β — meaning CGC is approximately 93% more volatile than CRON relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 72% for Canopy Growth Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — OGI or SNDL or CRON or CGC?

By revenue growth (latest reported year), Cronos Group Inc.

(CRON) is pulling ahead at 64. 4% versus -9. 5% for Canopy Growth Corporation (CGC). On earnings-per-share growth, the picture is similar: SNDL Inc. grew EPS 84. 1% year-over-year, compared to -100. 0% for Cronos Group Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — OGI or SNDL or CRON or CGC?

SNDL Inc.

(SNDL) is the more profitable company, earning -1. 7% net margin versus -222. 4% for Canopy Growth Corporation — meaning it keeps -1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNDL leads at -0. 5% versus -43. 5% for CGC. At the gross margin level — before operating expenses — CRON leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is OGI or SNDL or CRON or CGC more undervalued right now?

On forward earnings alone, Organigram Global Inc.

(OGI) trades at 9. 8x forward P/E versus 34. 3x for Cronos Group Inc. — 24. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CGC: 1180. 5% to $14. 47.

07

Which pays a better dividend — OGI or SNDL or CRON or CGC?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is OGI or SNDL or CRON or CGC better for a retirement portfolio?

For long-horizon retirement investors, Cronos Group Inc.

(CRON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1458% 10Y return). Canopy Growth Corporation (CGC) carries a higher beta of 1. 90 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRON: +1458%, CGC: -94. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between OGI and SNDL and CRON and CGC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OGI is a small-cap high-growth stock; SNDL is a small-cap quality compounder stock; CRON is a small-cap high-growth stock; CGC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

OGI

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 24%
  • Net Margin > 5%
Run This Screen
Stocks Like

SNDL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

CRON

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 100%
  • Gross Margin > 19%
Run This Screen
Stocks Like

CGC

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OGI and SNDL and CRON and CGC on the metrics below

Revenue Growth>
%
(OGI: 48.6% · SNDL: -4.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.